Life
PhRMA's Steve Ubl to Depart After Over a Decade of Leadership
Steve Ubl, the CEO of PhRMA, will resign at the end of the year, marking a notable shift in the pharmaceutical lobbying arena after leading for more than ten years.
editorial-staff
1 min read
Updated 1 day ago
Summary
Steve Ubl has announced his intention to step down as the chief executive of PhRMA at the end of this year. His tenure has spanned over a decade, during which he has been a prominent figure in pharmaceutical lobbying.
Ubl's departure is expected to significantly impact the landscape of pharmaceutical advocacy, especially as discussions around drug pricing and access continue to evolve.
As the head of the main trade group for brand-name drug manufacturers, Ubl's leadership has shaped many aspects of healthcare policy and industry practices.
Key Facts
| Fact | Value |
|---|---|
| Position | CEO of PhRMA |
| Tenure | Over a decade |
| Resignation Date | End of the year |
Updates
- No subsequent updates recorded.